Document is current

Any future updates will be listed below

Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis

Crossref DOI link: https://doi.org/10.1007/s40744-025-00782-6

Published Online: 2025-09-13

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark